Blazing a Trail

March/April

Read Article
  • Intravitreal Corticosteroids: Ensuring Effective Use With IOP Control

    Read Article
  • IOP CONTROL IN UNCONTROLLED GLAUCOMA

    Read Article
 

@GlaucomaToday

Visit @GlaucomaToday on Twitter

Articles From This Issue


 

Blazing a Trail

COVER FOCUS: Blazing a Trail

Its evolution sparked in 2004 by the FDA’s approval of the Trabectome (NeoMedix), microinvasive glaucoma surgery (MIGS) is here to stay. Lowering IOP safely and signific…

Chief Medical Editor’s Page

UP FRONT

This issue of GT celebrates the growing options for microinvasive glaucoma surgery (MIGS). Recent FDA approvals mean that glaucoma surgery can be performed using microsten…

The Literature

THE LITERATURE

Relationship Between Optical Coherence Tomography Angiography Vessel Density and Severity of Visual Field Loss in Glaucoma Yarmohammadi A, Zangwill LM, Diniz-Filho A, e…

 

GlaucomaToday Polls

View All

NEWS


 

First SMILE Laser Eye Surgery Procedures for US Navy Performed at Naval Medical …

The first Zeiss ReLEx SMILE procedures for US Navy personnel were performed by Cmdr. John B. Cason, …

Peer-Reviewed Paper Demonstrates the Benefits of Dropless Cataract Surgery

Imprimis Pharmaceuticals, an ophthalmology-focused pharmaceutical company, today announced the publi…

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Facebook Twitter

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.